STOCK TITAN

Geron Corp Financials

GERNW
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Geron Corp (GERNW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GERNW FY2025

Cash burn remains the defining operating mechanic, while liquidity is being managed through balance-sheet moves rather than meaningful sales.

Between FY2024 and FY2025, net loss nearly halved from $174.6M to $83.5M, but operating cash burn was still -$111.0M; cash stayed near $77.6M only because investing cash flow swung to $107.2M while financing added just $2.3M. That mix shows the business was still not funding itself from operations, and FY2025 liquidity was maintained mainly by converting other assets rather than by fresh capital or recurring revenue.

This is still a development-stage expense base: FY2025 R&D was $71.4M and SG&A was $159.3M, so costs are being carried largely without a real sales engine. The notable shift is where the spending sits—R&D fell from $125.0M in FY2023 while SG&A rose from $69.1M to $159.3M, implying a move away from research concentration toward broader operating infrastructure.

The balance sheet looks comfortable at first glance with a current ratio of 4.7x, but immediate liquidity is thinner than that headline suggests. Inventory rose from $38.7M in FY2024 to $116.6M in FY2025 while cash stayed around $77.6M, meaning a larger share of current assets is tied up outside cash.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 31 / 100
Financial Profile 31/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Geron Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage
91

Geron Corp carries a low D/E ratio of 0.53, meaning only $0.53 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
93

With a current ratio of 4.66, Geron Corp holds $4.66 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 93/100.

Returns
0

Geron Corp generates a -37.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -62.3% the prior year.

Piotroski F-Score Weak
1/9

Geron Corp passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality
1.33x

For every $1 of reported earnings, Geron Corp generates $1.33 in operating cash flow (-$111.0M OCF vs -$83.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-2.1x

Geron Corp earns $-2.1 in operating income for every $1 of interest expense (-$68.6M vs $32.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
-$68.1M
YoY+60.7%

Geron Corp's EBITDA was -$68.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 60.7% from the prior year.

Net Income
-$83.5M
YoY+52.2%

Geron Corp reported -$83.5M in net income in fiscal year 2025. This represents an increase of 52.2% from the prior year.

EPS (Diluted)
$-0.13
YoY+51.9%

Geron Corp earned $-0.13 per diluted share (EPS) in fiscal year 2025. This represents an increase of 51.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$77.6M
YoY-1.8%
5Y CAGR+50.9%
10Y CAGR+13.8%

Geron Corp held $77.6M in cash against $119.5M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
640M
YoY+5.5%
5Y CAGR+15.6%
10Y CAGR+15.0%

Geron Corp had 640M shares outstanding in fiscal year 2025. This represents an increase of 5.5% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
-37.0%
YoY+25.3pp
5Y CAGR-1.1pp
10Y CAGR-37.0pp

Geron Corp's ROE was -37.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 25.3 percentage points from the prior year.

Capital Allocation

R&D Spending
$71.4M
YoY-31.1%
5Y CAGR+6.8%
10Y CAGR+14.9%

Geron Corp invested $71.4M in research and development in fiscal year 2025. This represents a decrease of 31.1% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

GERNW Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $51.8M N/A $47.2M-3.7% $49.0M+23.8% $39.6M N/A $28.3M+3105.3% $882K
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses $15.0M N/A $21.1M-3.1% $21.7M+44.2% $15.1M N/A $20.2M-34.5% $30.8M
SG&A Expenses $35.4M N/A $39.0M+1.1% $38.6M-3.6% $40.0M N/A $35.9M-9.0% $39.4M
Operating Income $158K N/A -$13.9M-11.5% -$12.5M+25.4% -$16.7M N/A -$28.2M+59.3% -$69.3M
Interest Expense $7.1M N/A $8.6M+1.5% $8.5M+3.9% $8.2M N/A $3.0M-8.2% $3.3M
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$3.6M N/A -$18.4M-12.5% -$16.4M+17.4% -$19.8M N/A -$26.4M+60.8% -$67.4M
EPS (Diluted) $-0.01 N/A $-0.03-50.0% $-0.02+33.3% $-0.03 N/A $-0.04+60.0% $-0.10

GERNW Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $534.1M-6.4% $570.5M+0.6% $567.4M+2.2% $555.2M-1.3% $562.5M-5.3% $593.8M+33.4% $444.9M-1.0% $449.4M
Current Assets $498.5M-4.2% $520.3M-0.4% $522.3M+3.3% $505.6M+2.0% $495.8M+1.0% $491.0M+23.3% $398.1M+6.6% $373.3M
Cash & Equivalents $68.9M-11.2% $77.6M-0.7% $78.1M+0.5% $77.7M-7.2% $83.7M+6.0% $79.0M+30.9% $60.3M-48.4% $116.9M
Inventory $133.3M+14.3% $116.6M+22.2% $95.4M+38.0% $69.1M+23.0% $56.2M+45.2% $38.7M+90.9% $20.3M+2520.5% $774K
Accounts Receivable $41.9M+13.2% $37.0M+4.6% $35.4M-3.4% $36.6M+17.5% $31.2M-13.3% $35.9M+28.3% $28.0M+3104.5% $874K
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $305.0M-11.5% $344.7M+8.2% $318.7M+7.8% $295.7M+0.5% $294.2M-6.1% $313.5M+105.3% $152.7M+7.0% $142.7M
Current Liabilities $73.6M-34.0% $111.5M+27.2% $87.7M+36.4% $64.3M+2.0% $63.0M-28.6% $88.3M-36.0% $137.9M+33.2% $103.5M
Long-Term Debt $119.8M+0.2% $119.5M+0.2% $119.3M+0.2% $119.0M+0.2% $118.7M+0.2% $118.5M+865.2% $12.3M-66.4% $36.5M
Total Equity $229.1M+1.4% $225.9M-9.2% $248.7M-4.2% $259.5M-3.2% $268.2M-4.3% $280.3M-4.1% $292.3M-4.7% $306.7M
Retained Earnings -$1.9B-0.2% -$1.9B-1.6% -$1.8B-1.0% -$1.8B-0.9% -$1.8B-1.1% -$1.8B-1.5% -$1.7B-1.5% -$1.7B

GERNW Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$62.9M-185.1% -$22.1M-62.5% -$13.6M+50.5% -$27.4M+42.9% -$48.0M-9.2% -$43.9M+25.4% -$58.9M-10.2% -$53.5M
Capital Expenditures N/A N/A N/A N/A N/A -$141K $0-100.0% $206K
Free Cash Flow N/A N/A N/A N/A N/A -$44.1M+25.2% -$58.9M-9.8% -$53.7M
Investing Cash Flow $51.9M+145.2% $21.1M+58.4% $13.3M-34.3% $20.3M-61.3% $52.4M+150.7% -$103.5M-18584.3% -$554K+98.5% -$36.1M
Financing Cash Flow $2.4M+541.5% $378K-30.3% $542K-50.3% $1.1M+326.2% $256K-99.8% $166.2M+4544.0% $3.6M-78.7% $16.8M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

GERNW Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin 0.3% N/A -29.4%-4.0pp -25.4%+16.8pp -42.2% N/A -99.8%+7761.1pp -7860.9%
Net Margin -7.0% N/A -39.0%-5.6pp -33.4%+16.7pp -50.1% N/A -93.5%+7546.2pp -7639.8%
Return on Equity -1.6% N/A -7.4%-1.1pp -6.3%+1.1pp -7.4% N/A -9.0%+12.9pp -22.0%
Return on Assets -0.7% N/A -3.3%-0.3pp -2.9%+0.6pp -3.5% N/A -5.9%+9.0pp -15.0%
Current Ratio 6.78+2.1 4.66-1.3 5.96-1.9 7.870.0 7.87+2.3 5.56+2.7 2.89-0.7 3.61
Debt-to-Equity 0.520.0 0.53+0.0 0.48+0.0 0.46+0.0 0.44+0.0 0.42+0.4 0.04-0.1 0.12
FCF Margin N/A N/A N/A N/A N/A N/A -208.5%+5878.1pp -6086.6%

Frequently Asked Questions

No, Geron Corp (GERNW) reported a net income of -$83.5M in fiscal year 2025.

Geron Corp (GERNW) reported diluted earnings per share of $-0.13 for fiscal year 2025. This represents a 51.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Geron Corp (GERNW) had EBITDA of -$68.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Geron Corp (GERNW) had $77.6M in cash and equivalents against $119.5M in long-term debt.

Geron Corp (GERNW) has a return on equity of -37.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Geron Corp (GERNW) generated -$111.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Geron Corp (GERNW) had $570.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Geron Corp (GERNW) invested $71.4M in research and development during fiscal year 2025.

Geron Corp (GERNW) had 640M shares outstanding as of fiscal year 2025.

Geron Corp (GERNW) had a current ratio of 4.66 as of fiscal year 2025, which is generally considered healthy.

Geron Corp (GERNW) had a debt-to-equity ratio of 0.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Geron Corp (GERNW) had a return on assets of -14.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Geron Corp (GERNW) had $77.6M in cash against an annual operating cash burn of $111.0M. This gives an estimated cash runway of approximately 8 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Geron Corp (GERNW) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Geron Corp (GERNW) has an earnings quality ratio of 1.33x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Geron Corp (GERNW) has an interest coverage ratio of -2.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Geron Corp (GERNW) scores 31 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top